Skip to main content
NUVBHealthcare

Nuvation Bio Inc (NUVB) Insider Trading

In the last 90 days, 1 Nuvation Bio Inc (NUVB) insider reported no open-market purchases and 1 sale totaling $709,240. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026Gary HattersleyCHIEF SCIENTIFIC OFFICERSale100,000$7.09$709,240
Jun 23, 2026Philippe SauvageChief Financial OfficerSale47,668$6.01$286,370
Jun 23, 2026Stacy MarkelCHIEF PEOPLE OFFICERSale125,000$6.03$753,188
Jun 23, 2026Kerry WentworthCHIEF REGULATORY OFFICERSale63,000$6.02$379,191
Jun 9, 2026Robert MashalDirectorOpen Market Purchase25,000$4.73$118,250
Apr 17, 2026Dongfang LiuCHIEF MEDICAL OFFICERSale50,000$5.02$251,000
Apr 17, 2026Kerry WentworthCHIEF REGULATORY OFFICERSale36,750$5.01$184,279

Common questions

NUVB insider trading FAQ

Are NUVB insiders buying or selling?
Over the last 90 days, NUVB insiders were net sellers, reporting $0.00 of open-market purchases and $709,240 of sales.
When was the last NUVB insider purchase?
No open-market insider purchase of Nuvation Bio Inc stock was reported in the last 90 days.
Where does NUVB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Nuvation Bio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.